Bioinnovations in Brain Cancer Challenge Event

BIBC Challenge Event DATE: Friday, January 19, 2024—Saturday, January 20, 2024 TIME: 8:00 am—3:00 pm LOCATION: NCRC Dining Hall the BioInnovations in Brain Cancer Program in partnership with the Biointerfaces Institute will be hosting “Bioengineering in Brain Cancer” Challenge, on January 19th – 20th, 2024, at the North Campus Research Complex (NCRC). This is an event for UM faculty, clinicians and senior researchers to explore new ideas and catalyze…

Congratulations to the Lab Members who will be presenting posters at SNO Conference

Please check out the posters at the SNO conference Thursday November 16th-Sunday November 19th, 2023. Dr. Pedro Lowenstein/Anna Argento-“Brain tumors: from oncostreams to active liquid crystals”. Dr. Andrea Comba- “Targeting tumor-associated Smooth Muscle Actin (ACTA2) expression in mouse pre-clinical glioma models reduces tumor progression and extends survival”. Brandon McClellan-“Mutant isocitrate dehydrogenase 1 in glioma causes a reduction in adenosinergic pathway signaling within the tumor microenvironment”.…

Human Genetics Seminar Series-Presenting Dr. Pedro Lowenstein

“Gene Therapy for Brain Tumors: from brain/immune co-evolution to a novel therapy in humans” Presented by:Pedro Lowenstein, M.D., Ph.D.Richard C. Schneider Collegiate Professor of NeurosurgeryProfessor, Department of NeurosurgeryProfessor, Department of Cell and Developmental BiologyUniversity of Michigan Medical School Monday, October 2311:00 AM – 12:00 PM ESTBSRB – 1020 Kahn Auditorium Hosted by:Jordan Shavit, M.D., Ph.D.Professor of PediatricsProfessor of Human GeneticsHenry and Mala Dorfman Family Professor of Pediatric Hematology/OncologyUniversity…

Dr. Maria Castro asked to be a member of the AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship Committee

This committee is charged with selecting the recipient of the AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship, which serves to recognize an outstanding scientist who has made meritorious contributions to the cancer research field and who has, through leadership or by example, furthered the advancement of minority investigators in cancer research.